Výsledky vyhledávání - "Juergen Fleck"

Pasireotide long-acting release maintains biochemical control in patients with acromegaly: results from the extension of randomised, Phase III, PAOLA study

Autor: A. Colao, Albert Kandra, Thierry Brue, Gérald Raverot, Maria Fleseriu, Marcello D. Bronstein, Ilan Shimon, Mônica R. Gadelha, Mirtha Guitelman, Alberto M Pedroncelli, Vyacheslav Pronin, Mihail Coculescu, Juergen Fleck, Laura De Marinis

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ea4ded9f3e2de3d3baa53d3d69fd946
https://doi.org/10.1530/endoabs.37.ep810

Zobrazit plný text záznamu

Pasireotide LAR demonstrates superior efficacy versus octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: results from a phase III, multicentre, randomized study (PAOLA)

Autor: Kayo Kodama Lievre, Maria Fleseriu, Annamaria Colao, Mihail Coculescu, Mounir Aout, Vyacheslav Pronin, Thierry Brue, Marcello D. Bronstein, Gérald Raverot, Alberto M Pedroncelli, Juergen Fleck, Mirtha Guitelman, Ilan Shimon, Monica R Gadelha

Publikováno v: Endocrine Abstracts.

Lanreotide Autogel in Patients with Inadequately Controlled Acromegaly: Results from a Phase III, Multicentre, Randomized Study (PAOLA) M Gadelha,1 MD Bronstein,2 T Brue,3 M Coculescu,4 M Fleseriu,5 M Guitelman,6 V Pronin,7 G Raverot,8 I Shimon,9 K K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6294adf8e06292e5459b5aa22cb8c1de
https://doi.org/10.1530/endoabs.35.p907

Zobrazit plný text záznamu

Pasiréotide LP montre une efficacité supérieure versus octréotide LP et lanréotide Autogel chez les patients avec une acromégalie non contrôlée

Autor: Juergen Fleck, Delphine Drui, B. Verges, A. Tabarin, Ph. Chanson, Alberto M Pedroncelli, M. Aout, P. Caron, T. Brue, Gérald Raverot

Publikováno v: Annales d'Endocrinologie. 75:289-290

Objectif Cette etude randomisee de 24 semaines evalue l’analogue de la somatostatine multirecepteur pasireotide LP versus octreotide LP/lanreotide Autogel chez des patients acromegales non controles. Patients et methode Patient eligible : ≥ 18 an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::292940e00c48d8634bf8e34f295f6831
https://doi.org/10.1016/j.ando.2014.07.102

Zobrazit plný text záznamu

OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)

Autor: G. Raverot, Mônica R. Gadelha, Alberto M Pedroncelli, M. Guitelman, V. Pronin, Marcello D. Bronstein, A. Colao, Thierry Brue, M. Aout, Ilan Shimon, Juergen Fleck, M. Coculescu, Maria Fleseriu

Publikováno v: Growth Hormone & IGF Research. 24:S20-S21

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4db0cdcb761fcb960c573e2f2086ac8e
https://doi.org/10.1016/s1096-6374(14)50053-6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání